NPI: 1942626791 · LAS VEGAS, NV 89128 · 207W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,635 | $83K |
| 2019 | 10,305 | $452K |
| 2020 | 7,451 | $366K |
| 2021 | 6,992 | $332K |
| 2022 | 6,590 | $289K |
| 2023 | 5,404 | $694K |
| 2024 | 2,073 | $295K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92014 | 9,514 | 8,527 | $670K | |
| J0178 | Aflibercept injection | 776 | 449 | $537K |
| 92134 | 16,496 | 14,186 | $410K | |
| 67028 | 6,461 | 5,051 | $385K | |
| J2777 | Inj, faricimab-svoa, 0.1mg | 190 | 148 | $214K |
| J9035 | Bevacizumab injection | 3,823 | 2,900 | $165K |
| 99204 | 811 | 754 | $101K | |
| 99214 | 262 | 178 | $15K | |
| 67228 | 14 | 12 | $9K | |
| 76512 | 30 | 24 | $1K | |
| 92012 | 50 | 40 | $1K | |
| 99203 | 15 | 15 | $1K | |
| 1036F | 2,187 | 2,111 | $0.00 | |
| G8397 | Dil macula/fundus exam/w doc | 152 | 147 | $0.00 |
| 4177F | 14 | 14 | $0.00 | |
| G9903 | Pt scrn tbco id as non user | 134 | 130 | $0.00 |
| G8427 | Docrev cur meds by elig clin | 2,859 | 2,761 | $0.00 |
| 5010F | 154 | 149 | $0.00 | |
| 2022F | 494 | 469 | $0.00 | |
| G9974 | Mac exam perf | 14 | 14 | $0.00 |